title: How Much Portal Vein Flow Is Too Much for Liver Remnant in a Stable Porcine Model?
abstract: BACKGROUND
  There is increasing evidence that the occurrence of small-for-size syndrome (SFSS) depends on portal hemodynamics rather than graft size. The portal hyperperfusion has been regarded as the most important contributing factor to SFSS. However, it is unknown how much portal vein flow (PVF) or what limit of PVF the liver remnant can sustain in extreme hepatectomy. This study aimed to evaluate the limit of portal hyperperfusion in a stable porcine model.
  
  
  METHODS
  Twenty pigs were subjected to different liver resection volumes of 77%-82% (80% group; n = 6), 83%-87% (85% group; n = 7), and 88%-92% (90% group; n = 7). The survival rate, hemodynamic change, energy metabolism, lipopolysaccharide (LPS)/bacterial translocation, and injury and regeneration of the residual liver were observed after surgery.
  
  
  RESULTS
  All of the 80% group could sustain ∼4 times baseline PVF per unit volume, energy metabolism, and detoxifying functions, and survived to postoperative day (POD) 14. Only 3 animals in the 85% group, with ∼5.6 times baseline of PVF, were alive on POD 14, and in the 90% group, with >6 times baseline of PVF, undergoing severe hyperperfusion injury and LPS/bacterial translocation, none survived to POD 14.
  
  
  CONCLUSIONS
  The deaths of animals in the 85% group supports the hypothesis that the remnant vascular bed with 15% of liver volume represents a critical residual liver parenchyma in pigs, the safe minimum residual liver volume should be >15% of liver volume, indicating that the liver remnant can regenerate successfully in ∼5.6 times baseline of PVF, whereas it fails to regenerate in >5.6 times baseline of PVF.
authors.affiliation: Animal Experiment Centers, Chinese PLA General Hospital, Beijing, People's Republic of China.
authors.forename: L
authors.initials: L
authors.lastname: Xiang
authors.affiliation: Animal Experiment Centers, Chinese PLA General Hospital, Beijing, People's Republic of China.
authors.forename: L
authors.initials: L
authors.lastname: Huang
authors.affiliation: Beijing Vital River Laboratory Animal Technology, Beijing, People's Republic of China.
authors.forename: X
authors.initials: X
authors.lastname: Wang
authors.affiliation: Animal Experiment Centers, Chinese PLA General Hospital, Beijing, People's Republic of China.
authors.forename: Y
authors.initials: Y
authors.lastname: Zhao
authors.affiliation: Animal Experiment Centers, Chinese PLA General Hospital, Beijing, People's Republic of China.
authors.forename: Y
authors.initials: Y
authors.lastname: Liu
authors.affiliation: Department of Hepatobiliary Surgery, Hainan Hospital and Chinese PLA General Hospital, Beijing, People's Republic of China. Electronic address: tanjingwang02@aliyun.com.
authors.forename: J
authors.initials: J
authors.lastname: Tan
mesh_terms: D000818:Animals; D018988:Bacterial Translocation; D001783:Blood Flow Velocity; D004195:Disease Models, Animal; D004734:Energy Metabolism; D006439:Hemodynamics; D006498:Hepatectomy / Q000379:methods*; D008070:Lipopolysaccharides / Q000097:blood; D008099:Liver / Q000098:blood supply* / Q000473:pathology / Q000601:surgery; D008102:Liver Circulation; D008115:Liver Regeneration / Q000502:physiology*; D016031:Liver Transplantation; D009929:Organ Size; D017082:Portal Pressure; D011169:Portal Vein / Q000503:physiopathology* / Q000601:surgery; D015427:Reperfusion Injury / Q000097:blood / Q000209:etiology* / Q000503:physiopathology; D013552:Swine
chemical_list: D008070:Lipopolysaccharides